Streamline Genomics

Streamline Genomics is a Montreal-based bioinformatics company that provides an automated platform for clinical genomic data analysis. The company's technology is designed to help clinicians and researchers interpret complex genetic data quickly and accurately, facilitating personalized medicine and precision oncology. By streamlining the pipeline from raw sequencing data to clinical reports, the platform reduces the time and expertise required for genomic diagnostics. The platform is particularly focused on identifying variants in oncology and rare genetic diseases. In 2021, the company was acquired by Lallemand, a global leader in yeast and bacteria development, to enhance their research and development capabilities in genomics. This acquisition allows Lallemand to leverage Streamline's bioinformatics expertise across its various health and nutrition business units.